Stay updated on Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T22:13:38.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error page, with the site header and footer visible, indicating restricted access to the content.
    Difference
    18%
    Check dated 2026-09-19T22:20:29.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now reflects a new site revision (v3.6.6) replacing the previous version (v3.6.5). This appears to be a minor maintenance/update to the site interface and does not affect the study details.
    Difference
    0.1%
    Check dated 2026-08-29T20:16:37.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4, as a software version update. It does not modify the study details, eligibility criteria, or other user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T16:53:56.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The revision label on the page has been updated from v3.6.3 to v3.6.4, indicating a small underlying update to the site. The visible study details and navigation remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-25T08:21:51.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, indicating a minor metadata update to the page.
    Difference
    0.1%
    Check dated 2026-07-03T22:46:31.000Z thumbnail image

Stay in the know with updates to Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.